Publication number: 20250084091
Abstract: Described herein are compounds and methods for the treatment of coronavirus infection. The compounds can function as an inhibitor of the main protease (Mpro) of coronaviruses. The compounds can include diphenylmethyl piperazine derivatives, diphenylmethyl piperidine derivatives, diphenylmethylidene piperidine derivatives, tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen derivatives, tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen derivatives, 6,11-dihydrobenzo[c][1]benzoxepin derivatives, 6,11-dihydrobenzo[c][1]benzothiepin derivatives, 5,5-dioxo-6,11-dihydrobenzo[c][1]benzothiepin derivatives, and 6-oxo-5,11-dihydrobenzo[c][1]benzazepin derivatives, as well as pharmaceutically acceptable salts, hydrates, and prodrugs thereof.
Type:
Application
Filed:
May 4, 2022
Publication date:
March 13, 2025
Inventors:
James C. Sacchettini, Nian E. Zhou, Maloy Kumar Parai, Joonyoung Shin, Jeremy Lee Wood, Inna V. Krieger, Armando Flores, Arjun Acharya, Zhe Shi, Xuelin Bian, Su TANG, Radha Bam, Pradeep Kumar Jaiswal